DSpace at RU >

Search Results

Results 1-24 of 24.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease	Maicas Blasco, N.; Ferrandiz, M.L.; Brines, R.; Ibanez, L.; Cuadrado, A.; Koenders, M.I.; Berg, W.B. van den; Alcaraz, M.J.
	2011	Up-Regulation of the Inflammatory Response by Ovariectomy in Collagen-Induced Arthritis. Effects of Tin Protoporphyrin IX.	Ibanez, L.; Alcaraz, M.J.; Maicas Blasco, N.; Guede, D.; Caeiro, J.R.; Koenders, M.I.; Berg, W.B. van den; Ferrandiz, M.L.
	2011	Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice	Bluml, S.; Bonelli, M.; Niederreiter, B.; Puchner, A.; Mayr, G.; Hayer, S.; Koenders, M.I.; Berg, W.B. van den; Smolen, J.; Redlich, K.
	2011	Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1beta, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis	Koenders, M.I.; Marijnissen, R.J.; Devesa, I.; Lubberts, E.; Joosten, L.A.B.; Roth, J.; Lent, P.L.E.M. van; Loo, F.A.J. van de; Berg, W.B. van den
	2010	Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?	Koenders, M.I.; Berg, W.B. van den
	2010	Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis.	Joosten, L.A.B.; Netea, M.G.; Mylona, E.; Koenders, M.I.; Malireddi, R.K.; Oosting, M.; Stienstra, R.; Veerdonk, F.L. van de; Stalenhoef, A.F.H.; Giamarellos-Bourboulis, E.J.; Kanneganti, T.D.; Meer, J.W.M. van der
	2010	The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model.	Maicas, N.; Ferrandiz, M.L.; Devesa, I.; Motterlini, R.; Koenders, M.I.; Berg, W.B. van den; Alcaraz, M.J.
	2010	Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression.	Toh, M.L.; Gonzales, G.; Koenders, M.I.; Tournadre, A.; Boyle, D.; Lubberts, E.; Zhou, Y.; Firestein, G.S.; Berg, W.B. van den; Miossec, P.
	2009	12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis.	Kronke, G.; Katzenbeisser, J.; Uderhardt, S.; Zaiss, M.M.; Scholtysek, C.; Schabbauer, G.; Zarbock, A.; Koenders, M.I.; Axmann, R.; Zwerina, J.; Baenckler, H.W.; Berg, W.B. van den; Voll, R.E.; Kuhn, H.; Joosten, L.A.B.; Schett, G.
	2009	Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation.	Abdollahi-Roodsaz, S.; Joosten, L.A.B.; Koenders, M.I.; Brand, B.T. van den; Loo, F.A.J. van de; Berg, W.B. van den
	2009	Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.	Plater-Zyberk, C.; Joosten, L.A.B.; Helsen, M.M.A.; Koenders, M.I.; Baeuerle, P.A.; Berg, W.B. van den
	2009	Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.	Grevers, L.C.; Lent, P.L.E.M. van; Koenders, M.I.; Walgreen, B.; Sloetjes, A.W.; Nimmerjahn, F.; Verbeek, J.S.; Berg, W.B. van den
	2009	Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta.	Joosten, L.A.B.; Netea, M.G.; Fantuzzi, G.; Koenders, M.I.; Helsen, M.M.A.; Sparrer, H.; Pham, C.T.; Meer, J.W.M. van der; Dinarello, C.A.; Berg, W.B. van den
	2007	Amplifying elements of arthritis and joint destruction	Berg, W.B. van den; Lent, P.L.E.M. van; Joosten, L.A.B.; Abdollahi-Roodsaz, S.; Koenders, M.I.
	2006	Interleukin-17 and its relation to IL-1 and TNF in experimental arthritis	Koenders, M.I.
	2006	Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.	Koenders, M.I.; Joosten, L.A.B.; Berg, W.B. van den
	2006	Interleukin-17 acts independently of TNF-alpha under arthritic conditions.	Koenders, M.I.; Lubberts, E.; Loo, F.A.J. van de; Oppers-Walgreen, B.; Bersselaar, L.A.M. van den; Helsen, M.M.A.; Kolls, J.; Padova, F.E. Di; Joosten, L.A.B.; Berg, W.B. van den
	2005	The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models.	Lubberts, E.; Koenders, M.I.; Berg, W.B. van den
	2005	Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.	Koenders, M.I.; Lubberts, E.; Oppers-Walgreen, B.; Bersselaar, L.A.M. van den; Helsen, M.M.A.; Padova, F.E. Di; Boots, A.M.H.; Gram, H.; Joosten, L.A.B.; Berg, W.B. van den
	2005	Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.	Koenders, M.I.; Kolls, J.; Oppers-Walgreen, B.; Bersselaar, L.A.M. van den; Joosten, L.A.B.; Schurr, J.R.; Schwarzenberger, P.; Berg, W.B. van den; Lubberts, E.
	2005	Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.	Koenders, M.I.; Lubberts, E.; Oppers-Walgreen, B.; Bersselaar, L.A.M. van den; Helsen, M.M.A.; Kolls, J.; Joosten, L.A.B.; Berg, W.B. van den
	2004	Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice.	Hooge, A.S.K. de; Loo, F.A.J. van de; Koenders, M.I.; Bennink, M.B.; Arntz, O.J.; Kolbe, T.; Berg, W.B. van den
	2004	Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.	Joosten, L.A.B.; Smeets, R.L.L.; Koenders, M.I.; Bersselaar, L.A.M. van den; Helsen, M.M.A.; Oppers-Walgreen, B.; Lubberts, E.; Iwakura, Y.; Loo, F.A.J. van de; Berg, W.B. van den
	2004	Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.	Lubberts, E.; Koenders, M.I.; Oppers-Walgreen, B.; Bersselaar, L.A.M. van den; Coenen-de Roo, C.J.J.; Joosten, L.A.B.; Berg, W.B. van den

1